Lv1
58 积分 2023-03-20 加入
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
3个月前
已完结
An updated patent review of EZH2 inhibitors (2024–present)
3个月前
已完结
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
3个月前
已完结
Therapeutic Horizons in Targeting EZH2 With Dual and Non-PROTAC Inhibitor Molecules: Recent Achievements, Comparative Analysis, and Future Perspectives
3个月前
已完结
Polycomb repressive complexes as therapeutic targets in hematologic malignancies
3个月前
已完结
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies
3个月前
已完结
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity
4个月前
已完结
Retinoic acid and TGF-β orchestrate organ-specific programs of tissue residency
4个月前
已完结
Divergent molecular networks program functionally distinct CD8+skin-resident memory T cells
4个月前
已完结
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity
7个月前
已完结
皖公网安备34019202002308
